Patient-focused drug development: New FDA draft guidance delves into what’s important

Patient-focused drug development: New FDA draft guidance delves into what’s important

Source: 
Endpoints
snippet: 

The FDA on Monday published the second in a series of four guidance documents on patient-focused drug development, with this latest draft helping sponsors identify what is most important to patients with respect to their experience with disease burden and treatment.